Nature of tumour rejection antigens in ovarian cancer-Reference-Cited by-同舟云学术

Nature of tumour rejection antigens in ovarian cancer

Published:2018-06-13 Issue:2 Volume:155 Page:202-210
ISSN:0019-2805
Container-title:Immunology
language:en
Short-container-title:Immunology

Author:

Want Muzamil Y.¹,Lugade Amit A.¹,Battaglia Sebastiano¹,Odunsi Kunle¹

Affiliation:

1. Center For Immunotherapy; Roswell Park Comprehensive Cancer Center; Buffalo NY USA

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/imm.12951/fullpdf

Reference115 articles.

1. The treatment of malignant tumors by bacterial toxins as developed by the late William B. Coley, M.D., reviewed in the light of modern research;Nauts;Cancer Res,1946

2. The toxins of William B. Coley and the treatment of bone and soft-tissue sarcomas;McCarthy;Iowa Orthop J,2006

3. Cancer immunotherapies, their safety and toxicity;Alatrash;Expert Opin Drug Saf,2013

4. T-cell immunotherapy of cancer;Melief;Res Immunol,1991

5. Adoptive T cell therapy of tumors: mechanisms operative in the recognition and elimination of tumor cells;Greenberg;Adv Immunol,1991

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fatty Acid Metabolism-Related lncRNA Prognostic Signature for Serous Ovarian Carcinoma;Epigenomics;2024-02-15

2. Harnessing tumor immunogenomics: Tumor neoantigens in ovarian cancer and beyond;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-11

3. Clinical Relevance of Mortalin in Ovarian Cancer Patients;Cells;2023-02-23

4. Integration of local and systemic immunity in ovarian cancer: Implications for immunotherapy;Frontiers in Immunology;2022-11-10

5. Immunology and Immune Checkpoint Inhibition in Ovarian Cancer – Current Aspects;Geburtshilfe und Frauenheilkunde;2021-07-06